LITH — Bioelife Income Statement
0.000.00%
Last trade - 00:00
HealthcareHighly SpeculativeMicro Cap
2014 December 31st | 2015 December 31st | 2016 December 31st | 2017 December 31st | 2018 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 0 | 0 | 0 | 0 | 0 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 0.464 | 0.043 | 0.104 | 0.125 | -0.602 |
Operating Profit | -0.464 | -0.043 | -0.104 | -0.125 | 0.602 |
Total Net Non Operating Interest Income / Expense | |||||
Net Income Before Taxes | -0.498 | -0.082 | -0.21 | -0.247 | -0.337 |
Net Income After Taxes | -0.498 | -0.082 | -0.21 | -0.247 | -0.337 |
Net Income Before Extraordinary Items | |||||
Net Income | -0.498 | -0.082 | -0.21 | -0.247 | -0.337 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -0.498 | -0.082 | -0.21 | -0.247 | -0.337 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.442 | -0.053 | -0.092 | -0.101 | -0.389 |
Dividends per Share |